About the AlzMatch Study

The AlzMatch Study tests whether a single blood test, collected at community-based laboratories, can help speed clinical trial enrollment by identifying people more likely to experience changes in their brains associated with Alzheimer’s disease.

AlzMatch is helping us find people who are most eligible for Alzheimer’s prevention trials by way of a simple blood draw. AlzMatch is currently invite-only.

Why should I join AlzMatch?

Blood tests are the cutting edge of Alzheimer’s research, and you could be part of it! AlzMatch helps us find people who may be most eligible to participate in Alzheimer’s disease prevention studies.

Am I eligible to join AlzMatch?

You may be eligible if you are: 

  • A current participant in the Alzheimer Prevention Trials (APT) Webstudy 
  • Over 50 years of age
  • Have no diagnosis of dementia

What happens when I join AlzMatch?

Read & Sign
Consent Form

Schedule Blood Draw Online

Visit a Local Quest for Blood Draw

Learn if Eligible to Screen for Research Study

How is the study funded?

The AlzMatch Study is funded by several organizations including:

  • National Institutes of Health
  • Gates Ventures
  • Epstein Family Alzheimer’s Disease Research Collaboration
AlzMatch is supported by the National Institute on Aging (NIA) of the National Institutes of Health (NIH) under award number R01AG053798.

Who is involved with AlzMatch?

AlzMatch is being conducted in special partnership with the APT Webstudy, including leading Alzheimer’s disease researchers from the following institutions:

Brigham Health Brigham and Women's Hospital
Keck School of Medicine of USC Alzheimer's Therapeutic Research Institute
Cleveland Clinic